secwatch.observer — SEC 8-K summary
======================================

Issuer:     SIGA TECHNOLOGIES INC (SIGA)
CIK:        0001010086
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0001140361-23-009759
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SIGA reports FY2022 revenue $110.8M, net income $33.9M; international sales surge to $71M
--------------------------------------------------------------------------------

- FY2022 total revenues $110.8M (down from $133.7M in 2021); net income $33.9M ($0.46 diluted EPS vs $0.91).
- International product sales ~$71M from 12 new customers, up from $13M in 2021 and $3M in 2020.
- DoD awarded contracts up to ~$18M for oral TPOXX; ~$7M delivered in 2022, first DoD procurement.
- BARDA exercised options for ~$26M of IV TPOXX after FDA approval in May 2022.
- Paid special dividend $0.45/share and repurchased ~1.8M shares for ~$13M in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1010086/000114036123009759/0001140361-23-009759-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1010086/000114036123009759/brhc10048946_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-009759

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer